血清乙胺水平作为L-茶氨酸摄入指标与日本普通人群2型糖尿病风险
本研究在日本社区人群中探究血清乙胺水平(作为L-茶氨酸摄入指标)与2型糖尿病发病的关联。对2253名40-79岁无糖尿病居民随访7年,发现血清乙胺水平升高与2型糖尿病累积发病率降低显著相关,第四分位组较第一分位组的多变量校正HR为0.69(95%CI 0.49-0.98)。动力学分析提示每日两次摄入含8mg L-茶氨酸的绿茶产品时稳态最低浓度>5.90 ng/mL。
要点
- 血清乙胺水平升高与2型糖尿病发病风险降低独立相关。
- 第四分位组(≥5.29 ng/mL)较第一分位组HR为0.69(95%CI 0.49-0.98)。
- 中年、糖尿病前期、肥胖或胰岛素抵抗者中该趋势更明显。
核心结论
- 在日本普通人群中,较高的血清乙胺水平与2型糖尿病发病风险降低显著相关。
- 血清乙胺浓度可作为客观评估L-茶氨酸摄入的有用生物标志物。
研究设计与样本
- 前瞻性队列研究,纳入2253名40-79岁无糖尿病的日本社区居住居民,随访7年。
- 血清乙胺水平按四分位数分组:≤0.86、0.87-2.10、2.11-5.28、≥5.29 ng/mL。
- 对12名健康志愿者摄入含8mg L-茶氨酸的富L-茶氨酸绿茶产品后进行血清乙胺浓度动力学分析。
主要发现
- 随访期间282名受试者发生2型糖尿病。
- 年龄和性别校正的2型糖尿病累积发病率随血清乙胺水平升高而显著降低(P for trend = 0.04)。
- 多变量校正后,第四分位组较第一分位组的2型糖尿病风险显著降低(HR 0.69,95%CI 0.49-0.98)。
- 该风险降低趋势在中年、糖尿病前期、肥胖或胰岛素抵抗受试者中更明显。
- 动力学分析估计,每日两次摄入间隔12小时时稳态最低浓度>5.90 ng/mL。
临床怎么用
- 血清乙胺水平可作为评估L-茶氨酸摄入的客观生物标志物。
- 较高血清乙胺水平与2型糖尿病风险降低相关,尤其在中年及糖尿病前期、肥胖或胰岛素抵抗人群中更明显。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study investigated the association between serum ethylamine levels as an indicator of l-theanine consumption and the development of type 2 diabetes in a Japanese community. RESEARCH DESIGN AND METHODS: A total of 2,253 community-dwelling Japanese individuals aged 40-79 years without diabetes were monitored for 7 years. Serum ethylamine levels were divided into quartiles: ≤0.86, 0.87-2.10, 2.11-5.28, and ≥5.29 ng/mL. Kinetic analysis of serum ethylamine concentrations was performed after ingestion of l-theanine-rich green tea products containing 8 mg of l-theanine by 12 healthy volunteers. RESULTS: During follow-up, 282 subjects developed type 2 diabetes. The age- and sex-adjusted cumulative incidence of type 2 diabetes decreased significantly with elevating levels of serum ethylamine (P for trend = 0.04). This association remained unchanged after adjusting for potential confounding factors. The multivariable-adjusted hazard ratio (HR) for type 2 diabetes was significantly lower in the fourth quartile of serum ethylamine than in the first quartile (HR 0.69, 95% CI 0.49-0.98). This trend of decrease in diabetic risk across serum ethylamine levels was more prominent in middle-aged subjects and in subjects with prediabetes, obesity, or insulin resistance. Kinetic analysis estimated that the minimum concentration at the steady state was >5.90 ng/mL in the case of twice-daily ingestion with an interval of 12 h. CONCLUSIONS: Higher serum ethylamine was significantly associated with lower risk of the development of type 2 diabetes in a general Japanese population. The measurement of serum ethylamine concentration would be a useful biomarker for the objective estimation of l-theanine consumption.
引用
- Ninomiya T, Kanzaki N, Hirakawa Y, et al. Serum Ethylamine Levels as an Indicator of l-Theanine Consumption and the Risk of Type 2 Diabetes in a General Japanese Population: The Hisayama Study. Diabetes Care. 2019. PMID: 31076414. doi:10.2337/dc18-2655
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。